New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2014
18:00 EDTISISIsis down 6% after negative mention by Seeking Alpha contributor
The contributor, who is short ISIS Pharmaceuticals, said that the poor long-term safety and tolerability of Kynamro may also effect the company's entire second generation antisense pipeline. Reference Link
News For ISIS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2015
19:43 EDTISISIsis Pharmaceuticals management to meet with JPMorgan
Subscribe for More Information
April 8, 2015
16:11 EDTISISRegulus files to sell 3.3M shares for Isis Pharmaceuticals
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use